Non-Hodgkin Lymphoma

Fostamatinib successfully targets the B-cell receptor

Publish date: December 13, 2009

The B-cell receptor is present on both normal B cells and malignant B cells. Signaling through this receptor is necessary for B-cell maturation...

Publish date: October 27, 2009

The drug was approved under the FDA’s accelerated approval process, which allows drugs that meet unmet medical needs to be approved faster.

Publish date: March 11, 2009

Researchers say they have come one step closer to determining the cause of R-CHOP failure in diffuse large B-cell lymphoma (DLBCL) by ruling out a...